Miralles Gines Diego
SEC insider (Form 3/4/5 filer). CIK 0001773413. President & Head of R&D at Artiva Biotherapeutics, Inc. (ARTV) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in SAN DIEGO, CA.
Companies Miralles Gines Diego has filed insider reports for
- Artiva Biotherapeutics, Inc. (ARTV): Officer, President & Head of R&D
- Contineum Therapeutics, Inc. (CTNM): Director
Miralles Gines Diego
CIK: 0001773413
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 9, 2026ARTV
Artiva Biotherapeutics, Inc.
AwardDirect45K shares- - Jun 26, 2026CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
19K shares- - May 18, 2026ARTV
Artiva Biotherapeutics, Inc.
AwardDirect77.5K shares- - Jun 26, 2025CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
14.8K shares- - Jun 24, 2025ARTV
Artiva Biotherapeutics, Inc.
AwardDirectDirector Stock Option (Right to Buy)
13.8K shares- - Mar 14, 2025CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
29.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 9, 2026 |  ARTV Artiva Biotherapeutics, Inc. | Award | 45,000 | - | $0 | Direct |
| Jun 26, 2026 |  CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 19,000 | - | - | Direct |
| May 18, 2026 | ARTV Artiva Biotherapeutics, Inc. | Award | 77,500 | - | $0 | Direct |
| Jun 26, 2025 | CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 14,750 | - | - | Direct |
| Jun 24, 2025 | ARTV Artiva Biotherapeutics, Inc. | Award Director Stock Option (Right to Buy) | 13,750 | - | - | Direct |
| Mar 14, 2025 | CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 29,500 | - | - | Direct |
1-6 of 6 transactions